Shares of Bionano Genomics (NASDAQ:BNGO) declined on Friday right after the genome assessment company announced the pricing of its public inventory giving. As of 10:30 a.m. EST, Bionano’s share selling price was down 15%.
Bionano priced its providing of 29,016,393 shares of popular stock at $3.05 for every share. That was very well under the stock’s $5 closing cost on Thursday, and Bionano’s shares fell in sort.
The firm expects to elevate around $88.5 million. Bionano also gave underwriters a 30-working day choice to obtain an further 4,352,458 shares at the exact same value, which could provide in additional money. The stock sale is predicted to be completed on Jan. 12.
Bionano’s shares soared on Monday immediately after it released a study on autism hazard genes. Bionano’s diagnostic expert services